AMGN News
Amgen Inc.
$426.11
+$13.27(+3.21%)
65
Overall
80
Value
63
Tech
52
Quality
Market Cap
$230.37B
Volume
3.05M
52W Range
$288.00 - $447.03
Target Price
$403.61
AMGN news: the latest Amgen Inc. headlines, press releases and market updates, newest first.
Latest AMGN News
- Amgen Fine-Tunes Evenity Delivery in New Phase 1 StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 13, 2026
- Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and United Therapeutics (UTHR)TipRanks Newsroom · Oct 12, 2026
- Bank of America Securities Remains a Sell on Amgen (AMGN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 TrialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug RaceTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 6, 2026
- Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol FranchiseTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla GrowthTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
- Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim TrialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 17, 2026
- Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)TipRanks Newsroom · Sep 17, 2026
- Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 14, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $426.11 | +3.2% | 3.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |